New mRNA vaccine shows promise against childhood cancer
新型 mRNA 疫苗在兒童癌症治療上展現潛力
更新於: 2026年6月21日 上午01:45
Recent advancements in mRNA technology, famously used in COVID-19 vaccines, are now being harnessed to fight childhood cancer.
近期mRNA技術的進展，即廣為人知應用於COVID-19疫苗的技術，正被用來對抗兒童癌症。
Unlike traditional vaccines used for prevention, these therapeutic vaccines aim to 're-educate' the immune system to recognize and eliminate malignant cells that have previously evaded detection.
與用於預防的傳統疫苗不同，這些治療性疫苗旨在「重新教育」免疫系統，以辨識並清除以往曾逃避檢測的惡性腫瘤細胞。
For neuroblastoma, a highly aggressive cancer, scientists have developed a vaccine using self-assembling nanoparticles.
針對侵襲性強的神經母細胞瘤，科學家開發了一種利用自組裝奈米顆粒的疫苗。
Meanwhile, a groundbreaking clinical trial is launching in Australia to test personalized mRNA vaccines for children with brain cancer.
同時，一項開創性的臨床試驗正在澳大利亞啟動，旨在測試針對兒童腦癌的個性化mRNA疫苗。
Because every tumor is unique, each vaccine is custom-made for the individual patient, aiming to activate their immune system to fight their specific cancer.
由於每位患者的腫瘤皆不相同，每劑疫苗均為病患量身訂製，以活化其免疫系統來對抗其特定的癌症。
By offering a more precise alternative to conventional chemotherapy and radiation, this technology seeks to improve survival rates while minimizing the harsh side effects that often impact childhood cancer survivors.
這項技術提供了比傳統化療和放療更精準的替代方案，力求在提升存活率的同時，減輕常見於兒童癌症倖存者身上的嚴重副作用。
